Andrea Bauer

ORCID: 0000-0002-4411-3088
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Contact Dermatitis and Allergies
  • Allergic Rhinitis and Sensitization
  • Dermatology and Skin Diseases
  • Food Allergy and Anaphylaxis Research
  • Occupational exposure and asthma
  • Urticaria and Related Conditions
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous Melanoma Detection and Management
  • Pesticide Exposure and Toxicity
  • Skin Protection and Aging
  • Mast cells and histamine
  • Drug-Induced Adverse Reactions
  • Autoimmune Bullous Skin Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Animal testing and alternatives
  • Cutaneous lymphoproliferative disorders research
  • Nail Diseases and Treatments
  • Asthma and respiratory diseases
  • Medical Practices and Rehabilitation
  • Immunotoxicology and immune responses
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Medical and Health Sciences Research
  • Cancer and Skin Lesions
  • Indoor Air Quality and Microbial Exposure
  • Complementary and Alternative Medicine Studies

University Hospital Carl Gustav Carus
2015-2024

TU Dresden
2015-2024

Klinik und Poliklinik für Psychotherapie und Psychosomatik
2015-2024

Universität Hamburg
2011-2023

Oxfam
2023

Liechtenstein Institute
2023

John Wiley & Sons (United States)
2023

John Wiley & Sons (United Kingdom)
2023

Hudson Institute
2023

Bauer Research Foundation
2023

As robots are gradually leaving highly structured factory environments and moving into human populated environments, they need to possess more complex cognitive abilities. They do not only have operate efficiently safely in natural, but also be able achieve higher levels of cooperation communication with humans. Human–robot collaboration (HRC) is a research field wide range applications, future scenarios, potentially high economic impact. HRC an interdisciplinary area comprising classical...

10.1142/s0219843608001303 article EN International Journal of Humanoid Robotics 2008-03-01

In the majority of patients with chronic spontaneous urticaria, most currently available therapies do not result in complete symptom control. Ligelizumab is a next-generation high-affinity humanized monoclonal anti-IgE antibody. Data are limited regarding dose-response relationship ligelizumab and efficacy safety as compared omalizumab placebo who have moderate-to-severe urticaria that inadequately controlled H1-antihistamines at approved or increased doses, alone combination...

10.1056/nejmoa1900408 article EN New England Journal of Medicine 2019-10-02

Abstract Background Preventive measures to decrease the frequency and intensity of anaphylactic events are essential provide optimal care for allergic patients. Aggravating factors may trigger or increase severity anaphylaxis therefore need be recognized avoided. Objective To identify prioritize associated with an increased risk developing severe anaphylaxis. Methods Data from Anaphylaxis Registry (122 centers in 11 European countries) were used logistic regression models considering...

10.1111/all.13380 article EN Allergy 2018-01-10

Hand eczema is a common inflammatory skin disorder. Health care providers need continuously updated information about the management of hand to ensure best treatment for their patients.To update European Society Contact Dermatitis guideline on diagnosis, prevention, and eczema.The Guideline Development Group (GDG) was established behalf ESCD. A call interest launched via ESCD website members' mailing list. Appraisal evidence therapeutic preventive interventions applied structured method...

10.1111/cod.14035 article EN Contact Dermatitis 2021-12-31
Avner Reshef Thomas Buttgereit Stephen D. Betschel Teresa Caballero Henriette Farkas and 88 more Anete S. Grumach Michihiro Hide Ankur K. Jindal Hilary Longhurst Jonathan Peter Marc A. Riedl Yuxiang Zhi Werner Aberer Mohamed Abuzakouk Tariq Al Farsi Nashat Al Sukaiti Mona Al‐Ahmad Sabine Altrichter Emel Aygören-Pürsün M. L. Baeza Noemi Anna Bara Andrea Bauer Jonathan A. Bernstein Isabelle Boccon-Gibod Hanna Bonnekoh Laurence Bouillet Zenon Brzoza Anette Bygum Oscar Calderon Regis de Albuquerque Campos Freya Helena Campos Romero Mauro Cancian Herberto Jose Chong-Neto George Christoff Stefan Cimbollek Danny M. Cohn Timothy Craig Inna Danilycheva Razvigor Darlenski Aurélie Du-Thanh Luis Felipe Ensina Daria Fomina Luz Fonacier Atsushi Fukunaga Asli Gelincik Pedro Giavina-Bianchi Kiran Godse Mark Gompels Margarida Goncalo Maia Gotua Guillermo Guidos Fogelbach Mar Guilarte Alicja Kasperska-Zajac Constance H. Katelaris Tamar Kinaciyan Pavel Kolkhir Kanokvalai Kulthanan Marcin Kurowski Elena Latysheva Antti Lauerma David Launay Ramon Lleonart William Lumry Alejandro Malbrán Ramzy Mohammed Ali Iman Nasr Sandra Nieto‐Martinez Claudio Parisi Ruby Pawankar Macarena Piñero-Saavedra Todor A. Popov Grzegorz Porebski A. Prieto Polina Pyatilova Michael Rudenko Bülent Enis Şekerel Faradiba Sarquis Serpa Farrukh Sheikh Frank Siebenhaar Angèle Soria Maria Staevska Petra Staubach Marcin Stobiecki Simon Francis Thomsen Massimo Triggiani Anna Valerieva Solange Valle Nguyen Van Dinh Carolina Elisa Vera Ayala Anna Zalewska-Janowska Andrea Zanichelli Markus Magerl Marcus Maurer

10.1016/j.jaci.2024.03.024 article EN Journal of Allergy and Clinical Immunology 2024-04-25

Thymic epithelial tumors (TET) are rare neoplasms of the thymus with considerable histologic heterogeneity. This retrospective study focused on correlation WHO-defined TET histotypes survival and tumor recurrence in a large cohort patients receiving different modes treatment.Two hundred twenty-eight were followed for up to 21 years (median, 60 months; range, 1 252 months) after primary surgery. Forty-two received adjuvant radiotherapy (mean dose, 53 Gy), 33 chemotherapy.Seventy-six (88%) 86...

10.1200/jco.2004.10.113 article EN Journal of Clinical Oncology 2004-04-15

Summary Background Occupational contact dermatitis is one of the most common occupational diseases in E urope. In order to develop effective preventive measures, detailed and up‐to‐date data on incidence, main causes professions at risk are needed. Objectives To describe pattern patch test reactivity allergens uropean baseline series patients with different occupations. Methods We analysed collected by S urveillance ystem C ontact A llergy ( ESSCA ) network from 2002 2010, 11 countries....

10.1111/cod.12333 article EN Contact Dermatitis 2015-01-12

Background. The pattern of contact sensitization to the supposedly most important allergens assembled in baseline series differs between countries, presumably at least partly because exposure differences. Objectives. To describe prevalence tested consecutive patients years 2007 and 2008, discuss possible Methods. Data from 39 departments 11 European countries comprising Surveillance System on Contact Allergy network ( www.essca‐dc.org ) this period have been pooled analysed according common...

10.1111/j.1600-0536.2012.02070.x article EN Contact Dermatitis 2012-04-15

Background.Treatment with omalizumab, a humanized recombinant monoclonal anti-IgE antibody, results in clinical efficacy patients Chronic Spontaneous Urticaria (CSU).The mechanism of action omalizumab CSU has not been elucidated detail. Objectives.To determine the effects on levels high affinity IgE receptor-positive (FcεRI + ) and IgE-positive (IgE dermal cells blood basophils.Treatment safety were also assessed.Study design.In double-blind study, aged 18-75 years randomized to receive 300...

10.7150/thno.18304 article EN cc-by Theranostics 2017-01-01

Skin diseases constitute up to 40% of all notified occupational in most European countries, predominantly comprising contact dermatitis, urticaria, and skin cancer. While insufficient prevention work-related (WRSD) is a top-priority problem Europe, common standards for these conditions are lacking.To develop on management WRSD (OSD).Consensus amongst experts within dermatology was achieved with regard the definition minimum evidence-based WRSD/OSD.By definition, WRSDs/OSDs (partially or...

10.1111/jdv.14319 article EN Journal of the European Academy of Dermatology and Venereology 2017-06-01

The preservative methylisothiazolinone (MI) has become an important allergen, with a dramatic increase in sensitization prevalence being seen over the last few years.To examine risk factors associated MI sensitization, order to identify targets of prevention aimed at curtailing present epidemic.On basis contact allergy surveillance data collected by Information Network Departments Dermatology (www.ivkd.org), 2009-2012, course 28,922 patch tests MI, 500 ppm water, included series cosmetic...

10.1111/cod.12123 article EN Contact Dermatitis 2013-07-27

Contact allergy is a common condition and can severely interfere with daily life or professional activities. Due to changes in exposures, such as introduction of new substances, products formulations regulatory intervention, the spectrum contact sensitization changes.To evaluate current allergens present European baseline series (EBS) across Europe.Retrospective analysis data collected by Surveillance System on Allergies (ESSCA, www.essca-dc.org) consecutively patch-tested patients, 2013/14,...

10.1111/jdv.14423 article EN Journal of the European Academy of Dermatology and Venereology 2017-06-19

Most data on chronic spontaneous urticaria (CSU) originate from highly selected patient populations treated at specialized centres. Little is known about CSU characteristics and the burden of in routine clinical practice. AWARE (A World-wide Antihistamine-Refractory Evaluation) an ongoing global study designed to assess real-life setting.To describe baseline first 1539 German patients with H1-antihistamine-refractory CSU.This prospective non-interventional included (18-75 years) a diagnosis...

10.1111/cea.12900 article EN Clinical & Experimental Allergy 2017-02-04

Summary Epicutaneous patch testing is the diagnostic standard for detection of allergic contact dermatitis. The present guidelines are aimed at residents and board‐certified physicians in fields dermatology allergology as well other medical specialties involved establishing indication its execution patients with dermatitis forms delayed‐type hypersensitivity. target audience also includes health care providers insurance funds. Based on a systematic literature search formal consensus process...

10.1111/ddg.13956 article EN JDDG Journal der Deutschen Dermatologischen Gesellschaft 2019-10-01

Management of chronic hand eczema (CHE) remains a challenge; effective topical treatment is limited to corticosteroids.To assess the efficacy and safety novel, pan-Janus kinase inhibitor (delgocitinib) in patients with CHE.In this randomized, double-blind, phase IIa study, CHE received delgocitinib ointment 30 mg g-1 or vehicle for 8 weeks. The primary end point was proportion achieving success ['clear'/'almost clear' skin ≥ 2-point improvement Physician's Global Assessment disease severity...

10.1111/bjd.18469 article EN cc-by-nc-nd British Journal of Dermatology 2019-08-29

Summary Actinic keratoses (AK) are common lesions in light‐skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence‐based framework for clinical decision making, guideline “actinic keratosis carcinoma” was developed using highest level of methodology (S3) according regulations issued by Association...

10.1111/ddg.14048 article EN cc-by-nc-nd JDDG Journal der Deutschen Dermatologischen Gesellschaft 2020-03-01
Emek Kocatürk Andaç Salman Iván Chérrez-Ojeda Paulo Ricardo Criado Jonny Peter and 93 more Elif Cömert-Özer Mohamed Abuzakouk Rosana Câmara Agondi Mona Al‐Ahmad Sabine Altrichter Rand Arnaout L. Karla Arruda Riccardo Asero Andrea Bauer Moshe Ben‐Shoshan Jonathan A. Bernstein Mojca Bizjak Isabelle Boccon‐Gibod Hanna Bonnekoh Laurence Bouillet Zenon Brzoza Paula Busse Régis A. Campos Emily Carne Niall Conlon Roberta Fachini Jardim Criado Eduardo Magalhães de Souza Lima Semra Demir Joachim Dissemond Sibel Doğan Irina V. Dorofeeva Luís Felipe Ensina Ragıp Ertaş Silvia Ferrucci Ignasi Figueras‐Nart Daria Fomina Sylvie M. Franken Atsushi Fukunaga Ana M. Giménez‐Arnau Kiran Godse Margarida Gonçalo Maia Gotua Clive Grattan Carole Guillet Naoko Inomata Thilo Jakob Gül Karakaya Alicja Kasperska−Zając Constance H. Katelaris Mitja Košnik Dorota Krasowska Kanokvalai Kulthanan Muthu Sendhil Kumaran Claudia Lang José Ignacio Larco‐Sousa Elisavet Lazaridou Tabi A. Leslie Undine Lippert Oscar Calderón Llosa Michaël Makris Alexander Marsland Iris Medina Raisa Meshkova Esther Bastos Palitot Claudio Alberto Salvador Parisi Julia Pickert German D. Ramón Mónica Rodríguez-González Nelson Augusto Rosário Filho Michael Rudenko Krzysztof Rutkowski Jorge Sánchez Sibylle Schliemann Bülent Enis Şekerel Faradiba Sarquis Serpa E. Serra‐Baldrich Zhiqiang Song A. Soria Maria Staevska Petra Staubach Anna Tagka Shunsuke Takahagi Simon Francis Thomsen Regina Treudler Zahava Vadasz Solange Oliveira Rodrigues Valle Martijn B. A. van Doorn Christian Vestergaard Nicola Wagner Dahu Wang Liangchun Wang Bettina Wedi Paraskevi Xepapadaki Esra Yücel Anna Zalewska‐Janowska Zuotao Zhao Torsten Zuberbier Marcus Maurer

The COVID-19 pandemic dramatically disrupts health care around the globe. impact of on chronic urticaria (CU) and its management are largely unknown.To understand how CU patients affected by pandemic; specialists alter patient management; course in with COVID-19.Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed consultations, remote treatment, changes medications, clinical consequences.The severely impairs care, less than 50% weekly numbers...

10.1111/all.14687 article EN cc-by-nc Allergy 2020-12-07

Summary Basal cell carcinoma (BCC) is the most common malignant tumor among fair‐skinned individuals, and its incidence had been steadily rising in past decades. In order to maintain highest quality of patient care possible, German S2k guidelines were updated following a systematic literature search with participation all professional societies associations involved management disease. Part 2 addresses issues such as proper risk stratification, various therapeutic approaches, prevention well...

10.1111/ddg.13755 article EN JDDG Journal der Deutschen Dermatologischen Gesellschaft 2019-02-01

Summary Two employees of the National Health Service (NHS) in England developed severe allergic reactions following administration BNT162b2 vaccine against COVID-19 (coronavirus disease 2019). The British SmPC for already includes reference to a contraindication use individuals who have had an reaction or any its components. As precautionary measure, Medicines and Healthcare products Regulatory Agency (MHRA) has issued interim guidance NHS not vaccinate principle “patients with allergies”....

10.1007/s40629-020-00160-4 article EN cc-by Allergo Journal International 2021-02-24

Background Chronic hand eczema (CHE) is a burdensome disease, and new well-documented, safe efficacious treatments are warranted. In recent CHE phase IIa trial, the pan-Janus kinase (JAK) inhibitor delgocitinib in an ointment formulation was found to be well tolerated. Objectives This trial assessed dose response, efficacy safety of cream CHE. Methods this double-blind, IIb dose-ranging adults with history inadequate response or contraindication topical corticosteroids were randomized 1, 3,...

10.1111/bjd.21037 article EN cc-by-nc British Journal of Dermatology 2022-01-27

Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing value included allergens.To present current EBS testing, obtained in 53 departments 13 countries during 2019 2020.Anonymised or pseudonymised individual data partly aggregated on demographic/clinical characteristics rest were prospectively collected centrally pooled analysed.In 2020, 22 581 patients tested EBS. Sensitization to nickel remained most common...

10.1111/cod.14170 article EN cc-by-nc Contact Dermatitis 2022-06-09
Coming Soon ...